The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Defining Driver DNA Methylation Changes in Human Cancer
Open accessAbstract
Human malignant tumors are characterized by pervasive changes in the patterns of DNA methylation. These changes include a globally hypomethylated tumor cell genome and the focal hypermethylation of numerous 5′-cytosine-phosphate-guanine-3′ (CpG) islands, many of them associated with gene promoters. It has been challenging to link specific DNA methylation changes with tumorigenesis in a cause-and-effect relationship. Some evidence suggests that cancer-associated DNA hypomethylation may increase genomic instability. Promoter hypermethylation events can lead to silencing of genes functioning in pathways reflecting hallmarks of cancer, including DNA repair, cell cycle regulation, promotion of apoptosis or control of key tumor-relevant signaling networks. A convincing argument for a tumor-driving role of DNA methylation can be made when the same genes are also frequently mutated in cancer. Many of the most commonly hypermethylated genes encode developmental transcription factors, the methylation of which may lead to permanent gene silencing. Inactivation of such genes will deprive the cells in which the tumor may initiate from the option of undergoing or maintaining lineage differentiation and will lock them into a perpetuated stem cell-like state thus providing an additional window for cell transformation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
A bivalent chromatin structure marks key developmental genes in embryonic stem cells
Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.041 · Cited by 5,361
CpG islands and the regulation of transcription
Deaton, A. M., & Bird, A. (2011) · Genes & Development · doi:10.1101/gad.2037511 · Cited by 3,187
Hypomethylation distinguishes genes of some human cancers from their normal counterparts
Feinberg, A. P., & Vogelstein, B. (1983) · Nature · doi:10.1038/301089a0 · Cited by 2,437
Function and information content of DNA methylation
Schübeler, D. (2015) · Nature · doi:10.1038/nature14192 · Cited by 2,060
A gene hypermethylation profile of human cancer.
Esteller, M., Corn, P. G., Baylin, S. B., & Herman, J. G. (2001) · PubMed · Cited by 2,032
Weisenberger, D. J., Siegmund, K. D., Campan, M., Young, J., Long, T. I., Faasse, M. A., Kang, G. H., Widschwendter, M., Weener, D., Buchanan, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1834 · Cited by 1,990
Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,986
The Hippo pathway and human cancer
Harvey, K. F., Zhang, X., & Thomas, D. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3458 · Cited by 1,842
Conserved role of intragenic DNA methylation in regulating alternative promoters
Maunakea, A. K., Nagarajan, R. P., Bilenky, M., Ballinger, T. J., D’Souza, C., Fouse, S. D., Johnson, B. E., Hong, C., Nielsen, C., Zhao, Y., et al. (2010) · Nature · doi:10.1038/nature09165 · Cited by 1,743 · cited 2×
“The first is the silencing of one of two or more alternative promoters of a gene leading to a change in expression of specific transcript isoforms [39,42].”
BackgroundTET-mediated active DNA demethylation: mechanism, function and beyond
Wu, X., & Zhang, Y. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.33 · Cited by 1,661
Induction of tumors in mice by genomic hypomethylation
Gaudet, F., Hodgson, J. G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J. W., Leonhardt, H., & Jaenisch, R. (2003) · Science · doi:10.1126/science.1083558 · Cited by 1,499 · cited 2×
“Earlier studies with hypomorphic mouse mutants of Dnmt genes have suggested that methylation loss is potentially causative for cancer formation [28,29].”
BackgroundKane, M., Loda, M. F., Gaida, G. M., Lipman, J., Mishra, R., Goldman, H., Jessup, J. M., & Kolodner, R. D. (1997) · PubMed · Cited by 1,476
Chromosomal Instability and Tumors Promoted by DNA Hypomethylation
Eden, A., Gaudet, F., Waghmare, A., & Jaenisch, R. (2003) · Science · doi:10.1126/science.1083557 · Cited by 1,399
DNA-binding factors shape the mouse methylome at distal regulatory regions
Stadler, M. B., Murr, R., Burger, L., Ivanek, R., Lienert, F., Schöler, A., Nimwegen, E. V., Wirbelauer, C., Oakeley, E. J., Gaidatzis, D., et al. (2011) · Nature · doi:10.1038/nature10716 · Cited by 1,383
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
Costello, J. F., Frühwald, M. C., Smiraglia, D. J., Rush, L. J., Robertson, G. P., Gao, X., Wright, F. A., Feramisco, J. D., Peltomäki, P., Lang, J. C., et al. (2000) · Nature Genetics · doi:10.1038/72785 · Cited by 1,357
Esteller, M., Hamilton, S. R., Burger, P. C., Baylin, S. B., & Herman, J. G. (1999) · PubMed · Cited by 1,253
Schlesinger, Y., Straussman, R., Keshet, I., Farkash, S., Hecht, M., Zimmerman, J., Eden, E., Yakhini, Z., Ben-Shushan, E., Reubinoff, B. E., et al. (2007) · Nature Genetics · doi:10.1038/ng1950 · Cited by 1,226
Epigenetic Determinants of Cancer
Baylin, S. B., & Jones, P. A. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019505 · Cited by 1,226
Epigenetic stem cell signature in cancer
Widschwendter, M., Fiegl, H., Egle, D., Mueller-Holzner, E., Spizzo, G., Marth, C., Weisenberger, D. J., Campan, M., Young, J., Jacobs, I., et al. (2007) · Nature Genetics · doi:10.1038/ng1941 · Cited by 1,143
Ohm, J. E., McGarvey, K. M., Yu, X., Cheng, L., Schuebel, K. E., Cope, L., Mohammad, H. P., Chen, W., Daniel, V. C., Yu, W., et al. (2007) · Nature Genetics · doi:10.1038/ng1972 · Cited by 1,130
Dammann, R., Li, C., Yoon, J.-H., Chin, P. L., Bates, S., & Pfeifer, G. P. (2000) · Nature Genetics · doi:10.1038/77083 · Cited by 1,064
Self-citationSuzuki, H., Gabrielson, E., Chen, W., Anbazhagan, R., van Engeland, M., Weijenberg, M. P., Herman, J. G., & Baylin, S. B. (2002) · Nature Genetics · doi:10.1038/ng892 · Cited by 857
The 5-methylcytosine content of DNA from human tumors
Gama-Sosa, M. A., Slagel, V. A., Trewyn, R. W., Oxenhandler, R., Kuo, K. C., Gehrke, C. W., & Ehrlich, M. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.19.6883 · Cited by 844
Teitz, T., Wei, T., Valentine, M. B., Vanin, E. F., Grenet, J., Valentine, V. A., Behm, F. G., Look, A. T., Lahti, J. M., & Kidd, V. J. (2000) · Nature Medicine · doi:10.1038/75007 · Cited by 811
Intragenic DNA methylation prevents spurious transcription initiation
Neri, F., Rapelli, S., Krepelova, A., Incarnato, D., Parlato, C., Basile, G., Maldotti, M., Anselmi, F., & Oliviero, S. (2017) · Nature · doi:10.1038/nature21373 · Cited by 739
Gene Body-Specific Methylation on the Active X Chromosome
Hellman, A., & Chess, A. (2007) · Science · doi:10.1126/science.1136352 · Cited by 729
Berman, B. P., Weisenberger, D. J., Aman, J. F., Hinoue, T., Ramjan, Z., Liu, Y., Noushmehr, H., Lange, C. P. E., van Dijk, C. M., Tollenaar, R. A. E. M., et al. (2012) · Nature Genetics · doi:10.1038/ng.969 · Cited by 660
Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
Zöchbauer‐Müller, S., Fong, K. M., Virmani, A. K., Geradts, J., Gazdar, A. F., & Minna, J. D. (2001) · PubMed · Cited by 608
Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host
Timp, W., & Feinberg, A. P. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3486 · Cited by 586
Hypomethylation of ras oncogenes in primary human cancers
Feinberg, A. P., & Vogelstein, B. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(83)80115-6 · Cited by 514
Plumb, J. A., Strathdee, G. R., Sludden, J., Kaye, S. B., & Brown, R. E. (2000) · PubMed · doi:10.25405/ncl.34284429 · Cited by 486
DNA methylation and DNA methyltransferases
Edwards, J. R., Yarychkivska, O., Boulard, M., & Bestor, T. H. (2017) · Epigenetics & Chromatin · doi:10.1186/s13072-017-0130-8 · Cited by 484
Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes
Tubio, J. M. C., Li, Y., Ju, Y. S., Martincorena, I., Cooke, S. L., Tojo, M., Gundem, G., Pipinikas, C. P., Zamora, J., Raine, K., et al. (2014) · Science · doi:10.1126/science.1251343 · Cited by 412
Methylation of the BRCA1 gene in sporadic breast cancer.
Dobrovic, A., & Simpfendorfer, D. (1997) · PubMed · Cited by 370
Identification of a Novel Ras-Regulated Proapoptotic Pathway
Khokhlatchev, A., Rabizadeh, S., Xavier, R., Nedwidek, M., Chen, T., Zhang, X.-F., Seed, B., & Avruch, J. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00683-8 · Cited by 357
Catteau, A., Harris, W. H., Xu, C.-F., & Solomon, E. (1999) · Oncogene · doi:10.1038/sj.onc.1202509 · Cited by 354
A human B cell methylome at 100−base pair resolution
Rauch, T. A., Wu, X., Zhong, X., Riggs, A. D., & Pfeifer, G. P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812399106 · Cited by 333
Self-citationHigh-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer
Rauch, T. A., Zhong, X., Wu, X., Wang, M., Kernstine, K. H., Wang, Z., Riggs, A. D., & Pfeifer, G. P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710735105 · Cited by 318
Self-citationGlioma CpG island methylator phenotype (G-CIMP): biological and clinical implications
Malta, T. M., de Souza, C. F., Sabedot, T. S., Silva, T. C., Mosella, M. S., Kalkanis, S. N., Snyder, J., Castro, A. V. B., & Noushmehr, H. (2018) · Neuro-Oncology · doi:10.1093/neuonc/nox183 · Cited by 302
Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis
Patel, S. H., Camargo, F. D., & Yimlamai, D. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.10.047 · Cited by 297
The RASSF proteins in cancer; from epigenetic silencing to functional characterization
Richter, A. M., Pfeifer, G. P., & Dammann, R. H. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.03.004 · Cited by 295
Self-citationRauch, T., Li, H., Wu, X., & Pfeifer, G. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1888 · Cited by 292
Self-citationRauch, T., Wang, Z., Zhang, X., Zhong, X., Wu, X., Lau, S. K., Kernstine, K. H., Riggs, A. D., & Pfeifer, G. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701059104 · Cited by 287
Self-citationMutagenesis at Methylated CpG Sequences
Pfeifer, G. P. (2006) · Current Topics in Microbiology and Immunology · doi:10.1007/3-540-31390-7_10 · Cited by 262
Self-citationPaz, M. F., Yaya-Tur, R., Rojas-Marcos, I., Reynes, G., Pollan, M., Aguirre-Cruz, L., García-Lopez, J. L., Piquer, J., Safont, M.-J., Balaña, C., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0392 · Cited by 261
Oncogenic roles of DNA hypomethylation through the activation of cancer-germline genes
Van Tongelen, A., Loriot, A., & De Smet, C. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.03.029 · Cited by 241
Tumor suppressor genes in normal and malignant hematopoiesis
Krug, U., Ganser, A., & Koeffler, H. P. (2002) · Oncogene · doi:10.1038/sj.onc.1205322 · Cited by 231
DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas.
Baylin, S. B., Höppener, J. W. M., de Bustros, A., Steenbergh, P. H., Lips, C. J. M., & Nelkin, B. D. (1986) · PubMed · Cited by 220
Epigenetic changes of DNA repair genes in cancer
Lahtz, C., & Pfeifer, G. P. (2011) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjq053 · Cited by 217
Self-citationRASSF1A Is Part of a Complex Similar to the Drosophila Hippo/Salvador/Lats Tumor-Suppressor Network
Guo, C., Tommasi, S., Liu, L., Yee, J.-K., Dammann, R., & Pfeifer, G. P. (2007) · Current Biology · doi:10.1016/j.cub.2007.02.055 · Cited by 200
Self-citationThe tumor suppressor RASSF1A in human carcinogenesis: an update.
Dammann, R., Schagdarsurengin, U., Seidel, C., Strunnikova, M., Rastetter, M., Baier, K., & Pfeifer, G. P. (2005) · PubMed · doi:10.14670/hh-20.645 · Cited by 197
Self-citationDe Smet, C., Loriot, A., & Boon, T. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.11.4781-4790.2004 · Cited by 192
Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma
Seidel, C., Schagdarsurengin, U., Blümke, K., Würl, P., Pfeifer, G. P., Hauptmann, S., Taubert, H. W., & Dammann, R. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20317 · Cited by 184
Self-citationDNA Hypomethylation and Hemimethylation in Cancer
Ehrlich, M., & Lacey, M. R. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9967-2_2 · Cited by 174
Comparison of Methods for Quantification of Global DNA Methylation in Human Cells and Tissues
Lisanti, S., Omar, W. A. W., Tomaszewski, B., De Prins, S., Jacobs, G., Koppen, G., Mathers, J. C., & Langie, S. A. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079044 · Cited by 167
Identification of Driver and Passenger DNA Methylation in Cancer by Epigenomic Analysis
Kalari, S. K., & Pfeifer, G. P. (2010) · Advances in genetics · doi:10.1016/b978-0-12-380866-0.60010-1 · Cited by 158
Self-citationDNA methylation aberrancies as a guide for surveillance and treatment of human cancers
Liang, G., & Weisenberger, D. J. (2017) · Epigenetics · doi:10.1080/15592294.2017.1311434 · Cited by 147
CpG Island Hypermethylation in Human Astrocytomas
Wu, X., Rauch, T. A., Zhong, X., Bennett, W. P., Latif, F., Krex, D., & Pfeifer, G. P. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3631 · Cited by 144
Self-citationRomanov, G. A., & Vanyushin, B. F. (1981) · Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis · doi:10.1016/0005-2787(81)90156-8 · Cited by 143
Liu, L., Dai, Y., Chen, J., Zeng, T., Li, Y., Chen, L., Zhu, Y.-H., Li, J., Ma, S., Xie, D., et al. (2013) · Hepatology · doi:10.1002/hep.26677 · Cited by 128
Rodríguez‐Paredes, M., Bormann, F., Raddatz, G., Gutekunst, J., Lucena-Porcel, C., Köhler, F., Wurzer, E., Schmidt, K., Gallinat, S., Wenck, H., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03025-1 · Cited by 107
Hanley, M. P., Hahn, M. A., Li, A. X., Wu, X., Lin, J., Wang, J., Choi, A. H., Ouyang, Z., Fong, Y., Pfeifer, G. P., et al. (2017) · Oncogene · doi:10.1038/onc.2017.130 · Cited by 101
Self-citationSingh, P., Li, A. X., Tran, D. A., Oates, N., Kang, E.-R., Wu, X., & Szabó, P. E. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.06.004 · Cited by 73
APC hypermethylation for early diagnosis of colorectal cancer: a meta-analysis and literature review
Liang, T.-J., Wang, H.-X., Zheng, Y., Cao, Y.-Q., Wu, X., Xin Min, Z. H. O. U., & Dong, S. (2017) · Oncotarget · doi:10.18632/oncotarget.17576 · Cited by 73
Renaud, S., Loukinov, D. I., Alberti, L., Vostrov, A. A., Kwon, Y., Bosman, F. T., Lobanenkov, V. V., & Benhattar, J. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq827 · Cited by 70
Dynamic Regulation of DNA Methylation During Mammalian Development
Guibert, S., Forné, T., & Weber, M. (2009) · Epigenomics · doi:10.2217/epi.09.5 · Cited by 63
The DNA methylation landscape of human melanoma
Jin, S., Xiong, W., Wu, X., Yang, L., & Pfeifer, G. P. (2015) · Genomics · doi:10.1016/j.ygeno.2015.09.004 · Cited by 55
Self-citationTumor-specific MAGE proteins as regulators of p53 function
Ladelfa, M. F., Peche, L. Y., Toledo, M. F., Laiseca, J. E., Schneider, C., & Monte, M. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.05.031 · Cited by 38
Kiss, N. B., Kogner, P., Johnsen, J. I., Martinsson, T., Larsson, C., & Geli, J. (2012) · BMC Medical Genetics · doi:10.1186/1471-2350-13-83 · Cited by 27
Pfeifer, G. P. (2017) · Wiley eBooks · doi:10.1002/9780470015902.a0006159.pub2 · Cited by 6
Self-citation
Cited by
Murata, M. (2018) · Environmental Health and Preventive Medicine · doi:10.1186/s12199-018-0740-1 · Cited by 588
Liu, Q., Fang, L., Yu, G., Wang, D., Xiao, C.-L., & Wang, K. (2019) · Nature Communications · doi:10.1038/s41467-019-10168-2 · Cited by 324
Promoter DNA Hypermethylation and Paradoxical Gene Activation
Smith, J., Sen, S., Weeks, R. J., Eccles, M. R., & Chatterjee, A. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2020.02.007 · Cited by 274
The Basic Characteristics of the Pentraxin Family and Their Functions in Tumor Progression
Wang, Z., Wang, X., Zou, H., Dai, Z., Feng, S., Zhang, M., Xiao, G., Liu, Z., & Cheng, Q. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01757 · Cited by 73
Postwala, H., Shah, Y., Parekh, P. S., & Chorawala, M. R. (2023) · Medical Oncology · doi:10.1007/s12032-023-02201-8 · Cited by 26
Metadata
- Authors
- Pfeifer, G.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-04-12
- Volume
- 19
- Issue
- 4
- Pages
- 1166
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2797121391
- Cited by
- 323
- References
- 71
- FWCI
- 13.50
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.